Methods for neural differentiation of embryonic stem cells using protease passaging techniques

Details for Australian Patent Application No. 2009201414 (hide)

Owner BresaGen Inc. University Of Georgia Research Foundation, Inc.

Inventors Condie, Brian; Robins, Allan; Schulz, Thomas C.

Agent Pizzeys

Pub. Number AU-A-2009201414

Parent 2004227366

Filing date 9 April 2009

Wipo publication date 7 May 2009

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

30 April 2009 Complete Application Filed

7 May 2009 Application Open to Public Inspection

  Published as AU-A-2009201414

21 May 2009 Section 223 Application Allowed

  BresaGen Inc.; University Of Georgia Research Foundation, Inc. The time in which to make a further application for a divisional patent has been extended to 08 May 2009. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606

11 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods for neural differentiation of embryonic stem cells using protease passaging techniques

26 May 2011 Alteration of Name

  The name of the applicant has been altered to University Of Georgia Research Foundation, Inc.; ViaCyte Georgia, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201415-Rivet (self-drilling & sealable)

2009201413-Selective estrogen receptor modulators in combination with estrogens